title: The NLRP3 inflammasome functions as a negative regulator of tumorigenesis during colitis-associated cancer.
abstract: Colitis-associated cancer (CAC) is a major complication of inflammatory bowel diseases. We show that components of the inflammasome are protective during acute and recurring colitis and CAC in the dextran sulfate sodium (DSS) and azoxymethane + DSS models. Mice lacking the inflammasome adaptor protein PYCARD (ASC) and caspase-1 demonstrate increased disease outcome, morbidity, histopathology, and polyp formation. The increased tumor burden is correlated with attenuated levels of IL-1beta and IL-18 at the tumor site. To decipher the nucleotide-binding domain, leucine-rich-repeat-containing (NLR) component that is involved in colitis and CAC, we assessed Nlrp3 and Nlrc4 deficient mice. Nlrp3(-/-) mice showed an increase in acute and recurring colitis and CAC, although the disease outcome was less severe in Nlrp3(-/-) mice than in Pycard(-/-) or Casp1(-/-) animals. No significant differences were observed in disease progression or outcome in Nlrc4(-/-) mice compared with similarly treated wild-type animals. Bone marrow reconstitution experiments show that Nlrp3 gene expression and function in hematopoietic cells, rather than intestinal epithelial cells or stromal cells, is responsible for protection against increased tumorigenesis. These data suggest that the inflammasome functions as an attenuator of colitis and CAC.
authors.affiliation: Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
authors.forename: Irving C
authors.initials: IC
authors.lastname: Allen
authors.forename: Erin McElvania
authors.initials: EM
authors.lastname: TeKippe
authors.forename: Rita-Marie T
authors.initials: RM
authors.lastname: Woodford
authors.forename: Joshua M
authors.initials: JM
authors.lastname: Uronis
authors.forename: Eda K
authors.initials: EK
authors.lastname: Holl
authors.forename: Arlin B
authors.initials: AB
authors.lastname: Rogers
authors.forename: Hans H
authors.initials: HH
authors.lastname: Herfarth
authors.forename: Christian
authors.initials: C
authors.lastname: Jobin
authors.forename: Jenny P-Y
authors.initials: JP
authors.lastname: Ting
mesh_terms: D000818:Animals; D051017:Apoptosis Regulatory Proteins; D053468:CARD Signaling Adaptor Proteins; D002352:Carrier Proteins / Q000235:genetics*; D003092:Colitis / Q000150:complications*; D003106:Colon / Q000378:metabolism / Q000473:pathology; D003598:Cytoskeletal Proteins / Q000172:deficiency / Q000235:genetics; D005065:Euthanasia; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000150:complications*; D020382:Interleukin-18 / Q000378:metabolism; D053583:Interleukin-1beta / Q000378:metabolism; D051379:Mice; D018345:Mice, Knockout; D000071199:NLR Family, Pyrin Domain-Containing 3 Protein; D009369:Neoplasms / Q000209:etiology* / Q000473:pathology / Q000517:prevention & control; D047368:Tumor Burden
chemical_list: D051017:Apoptosis Regulatory Proteins; D053468:CARD Signaling Adaptor Proteins; D002352:Carrier Proteins; D003598:Cytoskeletal Proteins; D020382:Interleukin-18; D053583:Interleukin-1beta; D000071199:NLR Family, Pyrin Domain-Containing 3 Protein; C453881:NLRP3 protein, human; C492716:Nlrp3 protein, mouse; C498534:Pycard protein, mouse
references.citation: Nature. 2001 Jul 5;412(6842):99
references.pmid: 11808612
references.citation: Cell. 2004 Aug 6;118(3):285-96
references.pmid: 15294155
references.citation: Nature. 2001 May 31;411(6837):603-6
references.pmid: 11385577
references.citation: Immunity. 2006 Mar;24(3):317-27
references.pmid: 16546100
references.citation: J Immunol. 1995 Mar 1;154(5):2434-40
references.pmid: 7868909
references.citation: Nature. 2004 Jul 8;430(6996):213-8
references.pmid: 15190255
references.citation: Nature. 2008 Jun 19;453(7198):1122-6
references.pmid: 18496530
references.citation: Cancer Cell. 2009 Sep 8;16(3):208-19
references.pmid: 19732721
references.citation: Nat Protoc. 2007;2(8):1998-2004
references.pmid: 17703211
references.citation: J Biol Chem. 1999 Nov 26;274(48):33835-8
references.pmid: 10567338
references.citation: PLoS One. 2009 Jun 24;4(6):e6026
references.pmid: 19551144
references.citation: Semin Immunol. 2009 Aug;21(4):194-8
references.pmid: 19501527
references.citation: J Clin Invest. 2008 Jul;118(7):2516-25
references.pmid: 18521188
references.citation: Curr Opin Pharmacol. 2009 Dec;9(6):680-7
references.pmid: 19828376
references.citation: Nature. 2006 Mar 9;440(7081):237-41
references.pmid: 16407889
references.citation: J Gastroenterol. 2005 Jan;40(1):16-23
references.pmid: 15692785
references.citation: Nature. 2009 Mar 26;458(7237):509-13
references.pmid: 19158676
references.citation: Int J Cancer. 2010 Apr 15;126(8):1838-1849
references.pmid: 19795419
references.citation: Cell. 1993 Nov 19;75(4):653-60
references.pmid: 8242741
references.citation: J Immunol. 2008 Jul 1;181(1):17-21
references.pmid: 18566365
references.citation: Gut. 2001 Apr;48(4):526-35
references.pmid: 11247898
references.citation: J Immunol. 2006 Oct 1;177(7):4252-6
references.pmid: 16982856
references.citation: Front Biosci. 2008 May 01;13:3494-505
references.pmid: 18508451
references.citation: Nature. 2009 Mar 26;458(7237):514-8
references.pmid: 19158675
references.citation: Cell. 2006 Feb 24;124(4):783-801
references.pmid: 16497588
references.citation: Immunity. 1998 Jul;9(1):143-50
references.pmid: 9697844
references.citation: Immunity. 2004 Mar;20(3):319-25
references.pmid: 15030775
references.citation: Br J Cancer. 2000 Dec;83(11):1443-7
references.pmid: 11076651
references.citation: Cancer Res. 1974 Sep;34(9):2368-72
references.pmid: 4843537
references.citation: Nat Genet. 2009 Jan;41(1):71-6
references.pmid: 19098911
references.citation: Cell. 2004 Jul 23;118(2):229-41
references.pmid: 15260992
references.citation: Nature. 2002 Dec 19-26;420(6917):860-7
references.pmid: 12490959
references.citation: J Immunol. 2006 Sep 15;177(6):3507-13
references.pmid: 16951308
references.citation: Science. 2007 Jul 6;317(5834):124-7
references.pmid: 17615359
references.citation: Clin Exp Immunol. 1995 Nov;102(2):379-83
references.pmid: 7586694
references.citation: Proc Natl Acad Sci U S A. 2001 Nov 6;98(23):13249-54
references.pmid: 11606779
references.citation: Nat Rev Immunol. 2006 Oct;6(10):715-27
references.pmid: 16977338
references.citation: Cancer Res. 2007 Dec 15;67(24):11594-600
references.pmid: 18089788
references.citation: Immunol Rev. 2009 Jan;227(1):95-105
references.pmid: 19120479
references.citation: Nat Immunol. 2009 Mar;10(3):266-72
references.pmid: 19158679
references.citation: J Immunol. 2008 Feb 15;180(4):2011-7
references.pmid: 18250403
references.citation: Am J Physiol Gastrointest Liver Physiol. 2005 May;288(5):G1055-65
references.pmid: 15826931
references.citation: Dig Dis Sci. 2007 Jul;52(7):1642-52
references.pmid: 17393315